Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB)
CUSIP: 034569103
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 41,587,315
- Total 13F shares
- 4,193,307
- Share change
- +10,093
- Total reported value
- $25,818,000
- Price per share
- $6.21
- Number of holders
- 8
- Value change
- +$61,833
- Number of buys
- 3
- Number of sells
- 2
Quarterly Holders Quick Answers
What is CUSIP 034569103?
CUSIP 034569103 identifies ANEB - Anebulo Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 034569103:
Top shareholders of ANEB - Anebulo Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| 22NW, LP |
13F
|
Company |
8%
|
3,343,565
|
$21,900,000 | — | 30 Sep 2021 | |
| MANGROVE PARTNERS IM, LLC |
13F
|
Company |
1%
|
416,546
|
$2,728,000 | — | 30 Sep 2021 | |
| Laurion Capital Management LP |
13F
|
Company |
0.54%
|
225,000
|
$1,514,000 | — | 30 Sep 2021 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.41%
|
172,309
|
$1,160,000 | — | 30 Sep 2021 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
17,333
|
$114,000 | — | 30 Sep 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.02%
|
7,613
|
$50,000 | — | 30 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
848
|
$6,000 | — | 30 Sep 2021 |
Institutional Holders of Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) as of Q4 2021
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.